[Fluid and sodium balance and blood pressure control in APD/CAPD]

Area of Science:

• Nephrology
• Cardiovascular Medicine

Background:

• Cardiovascular disease is the primary cause of death in ESRD patients, often linked to hypertension.
• Peritoneal dialysis (PD) initially shows benefits in hypertension control, but this effect may not be sustained over time.
• A U-shaped trend in hypertension has been observed in PD patients, linked to fluid retention and reduced sodium removal.

Purpose of the Study:

• To investigate strategies for improving blood pressure control in end-stage renal disease (ESRD) patients undergoing peritoneal dialysis (PD).
• To highlight the role of ultrafiltration, sodium elimination monitoring, and dietary interventions in managing hypertension in PD patients.

Main Methods:

• Reviewing early studies on PD and hypertension.
• Analyzing the U-shaped trend of hypertension in PD patients.
• Evaluating the impact of fluid retention and sodium removal on blood pressure.
• Assessing the contribution of biocompatible PD fluids and icodextrin.
• Considering innovative PD solutions like Low Sodium PDF and Bimodal Ultrafiltration.

Main Results:

• Hypertension control in PD patients can be challenging due to sustained increases in blood pressure.
• Fluid retention and decreased sodium removal over time contribute to worsening hypertension.
• Optimized ultrafiltration strategies, frequent sodium monitoring, and dietician counseling can improve fluid and sodium balance.
• Advances in PD fluid biocompatibility and the use of icodextrin are key interventions.

Conclusions:

• Personalized ultrafiltration strategies and diligent monitoring of sodium elimination are essential for effective hypertension management in PD patients.
• Dietary counseling plays a vital role in achieving better fluid and sodium balance.
• Further research into novel PD solutions is needed to enhance fluid and sodium removal in continuous ambulatory/automated peritoneal dialysis (CAPD/APD).